Thank you Yoda
Great interview, was a great day - I wasn't on the net all day, it is nice to be able to come home, bring up the board, and see all the news.
Brazil is a pure medical play, Bedrocan is a pure medical play -
two distinct separate market segments
what I really like about the last two deals - Bruce is shopping for cheap value the world over. Get 20% of Auscan for advice, get 50% of whatever this Brazil thing is for 'a couple hundred k'
what is this really - we are providing Brazilian universities the cannabis, they will be using Brazilian public funding to do pharmaceutical research on cannabis for the benefit of 200 million Brazilian people - BUT - because we have the Bedrocan strains, we have that intellectual property rights in South America - our upside - we get to go to the rest of the world with this Brazilian research and intellectual property and we get to commercialize it.
He mentioned Parkinson's 2 times - they will be performing disease specific drug trials - just like pharmaceutical companies - I think I hear a bell ringing - DIN DIN DIN
News 
Market Data 
Discover 
